Hyun Jeong Lee1, Eun-Chong Lee2, Seongho Seo3, Kwang-Pil Ko4, Jae Myeong Kang5, Woo-Ram Kim6, Ha-Eun Seo6, Sang-Yoon Lee3, Yeong-Bae Lee7, Kee Hyung Park7, Byeong Kil Yeon5, Nobuyuki Okamura8, Duk L Na9,10, Joon-Kyung Seong2,11,12, Young Noh7,13. 1. Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea. 2. School of Biomedical Engineering, Korea University, Seoul, South Korea. 3. Department of Neuroscience, College of Medicine, Gachon University, Incheon, South Korea. 4. Department of Preventive Medicine, Gachon University College of Medicine, Incheon, South Korea. 5. Department of Psychiatry, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea. 6. Neuroscience Research Institute, Gachon University, Incheon, South Korea. 7. Department of Neurology, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea. 8. Division of Pharmacology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan. 9. Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. 10. Neuroscience Center, Samsung Medical Center, Seoul, South Korea. 11. Department of Artificial Intelligence, Korea University, Seoul, South Korea. 12. Interdisciplinary Program in Precision Public Health, Korea University, Seoul, South Korea. 13. Department of Health Science and Technology, GAIHST, Gachon University, Incheon, South Korea.
Abstract
Background: Mild cognitive impairment (MCI) is a condition with diverse causes and clinical outcomes that can be categorized into subtypes. [18F]THK5351 has been known to detect reactive astrogliosis as well as tau which is accompanied by neurodegenerative changes. Here, we identified heterogeneous groups of MCI patients using THK retention patterns and a graph theory approach, allowing for the comparison of risk of progression to dementia in these MCI subgroups. Methods: Ninety-seven participants including 60 MCI patients and individuals with normal cognition (NC, n = 37) were included and undertook 3T MRI, [18F]THK5351 PET, and detailed neuropsychological tests. [18F]Flutemetamol PET was also performed in 62 participants. We calculated similarities between MCI patients using their regional standardized uptake value ratio of THK retention in 75 ROIs, and clustered subjects with similar retention patterns using the Louvain method based on the modularity of the graph. The clusters of patients identified were compared with an age-matched control group using a general linear model. Dementia conversion was evaluated after a median follow-up duration of 34.6 months. Results: MCI patients were categorized into four groups according to their THK retention patterns: (1) limbic type; (2) diffuse type; (3) sparse type; and (4) AD type (retention pattern as in AD). Subjects of the limbic type were characterized by older age, small hippocampal volumes, and reduced verbal memory and frontal/executive functions. Patients of the diffuse type had relatively large vascular burden, reduced memory capacity and some frontal/executive functions. Co-morbidity and mortality were more frequent in this subgroup. Subjects of the sparse type were younger and declined only in terms of visual memory and attention. No individuals in this subgroup converted to dementia. Patients in the AD type group exhibited the poorest cognitive function. They also had the smallest hippocampal volumes and the highest risk of progression to dementia (90.9%). Conclusion: Using cluster analyses with [18F]THK5351 retention patterns, it is possible to identify clinically-distinct subgroups of MCI patients and those at greater risk of progression to dementia.
Background: Mild cognitive impairment (MCI) is a condition with diverse causes and clinical outcomes that can be categorized into subtypes. [18F]THK5351 has been known to detect reactive astrogliosis as well as tau which is accompanied by neurodegenerative changes. Here, we identified heterogeneous groups of MCI patients using THK retention patterns and a graph theory approach, allowing for the comparison of risk of progression to dementia in these MCI subgroups. Methods: Ninety-seven participants including 60 MCI patients and individuals with normal cognition (NC, n = 37) were included and undertook 3T MRI, [18F]THK5351 PET, and detailed neuropsychological tests. [18F]Flutemetamol PET was also performed in 62 participants. We calculated similarities between MCI patients using their regional standardized uptake value ratio of THK retention in 75 ROIs, and clustered subjects with similar retention patterns using the Louvain method based on the modularity of the graph. The clusters of patients identified were compared with an age-matched control group using a general linear model. Dementia conversion was evaluated after a median follow-up duration of 34.6 months. Results: MCI patients were categorized into four groups according to their THK retention patterns: (1) limbic type; (2) diffuse type; (3) sparse type; and (4) AD type (retention pattern as in AD). Subjects of the limbic type were characterized by older age, small hippocampal volumes, and reduced verbal memory and frontal/executive functions. Patients of the diffuse type had relatively large vascular burden, reduced memory capacity and some frontal/executive functions. Co-morbidity and mortality were more frequent in this subgroup. Subjects of the sparse type were younger and declined only in terms of visual memory and attention. No individuals in this subgroup converted to dementia. Patients in the AD type group exhibited the poorest cognitive function. They also had the smallest hippocampal volumes and the highest risk of progression to dementia (90.9%). Conclusion: Using cluster analyses with [18F]THK5351 retention patterns, it is possible to identify clinically-distinct subgroups of MCI patients and those at greater risk of progression to dementia.
Authors: Douglas N Greve; David H Salat; Spencer L Bowen; David Izquierdo-Garcia; Aaron P Schultz; Ciprian Catana; J Alex Becker; Claus Svarer; Gitte M Knudsen; Reisa A Sperling; Keith A Johnson Journal: Neuroimage Date: 2016-02-23 Impact factor: 6.556
Authors: Hee Jin Kim; Seongbeom Park; Hanna Cho; Young Kyoung Jang; Jin San Lee; Hyemin Jang; Yeshin Kim; Ko Woon Kim; Young Hoon Ryu; Jae Yong Choi; Seung Hwan Moon; Michael W Weiner; William J Jagust; Gil D Rabinovici; Charles DeCarli; Chul Hyoung Lyoo; Duk L Na; Sang Won Seo Journal: JAMA Neurol Date: 2018-08-01 Impact factor: 18.302
Authors: Young Noh; Seun Jeon; Jong Min Lee; Sang Won Seo; Geon Ha Kim; Hanna Cho; Byoung Seok Ye; Cindy W Yoon; Hee Jin Kim; Juhee Chin; Kee Hyung Park; Kenneth M Heilman; Duk L Na Journal: Neurology Date: 2014-10-24 Impact factor: 9.910
Authors: A Ishiki; R Harada; N Okamura; N Tomita; C C Rowe; V L Villemagne; K Yanai; Y Kudo; H Arai; S Furumoto; M Tashiro; K Furukawa Journal: Eur J Neurol Date: 2016-10-31 Impact factor: 6.089
Authors: J Saura; J M Luque; A M Cesura; M Da Prada; V Chan-Palay; G Huber; J Löffler; J G Richards Journal: Neuroscience Date: 1994-09 Impact factor: 3.590
Authors: Keith A Johnson; Aaron Schultz; Rebecca A Betensky; J Alex Becker; Jorge Sepulcre; Dorene Rentz; Elizabeth Mormino; Jasmeer Chhatwal; Rebecca Amariglio; Kate Papp; Gad Marshall; Mark Albers; Samantha Mauro; Lesley Pepin; Jonathan Alverio; Kelly Judge; Marlie Philiossaint; Timothy Shoup; Daniel Yokell; Bradford Dickerson; Teresa Gomez-Isla; Bradley Hyman; Neil Vasdev; Reisa Sperling Journal: Ann Neurol Date: 2015-12-15 Impact factor: 10.422
Authors: Sonja Schönecker; Matthias Brendel; Carla Palleis; Leonie Beyer; Günter U Höglinger; Elisabeth Schuh; Boris-Stephan Rauchmann; Julia Sauerbeck; Guido Rohrer; Stefan Sonnenfeld; Katsutoshi Furukawa; Aiko Ishiki; Nobuyuki Okamura; Peter Bartenstein; Marianne Dieterich; Kai Bötzel; Adrian Danek; Axel Rominger; Johannes Levin Journal: Front Aging Neurosci Date: 2019-09-11 Impact factor: 5.750
Authors: Konstantinos Chiotis; Laure Saint-Aubert; Irina Savitcheva; Vesna Jelic; Pia Andersen; My Jonasson; Jonas Eriksson; Mark Lubberink; Ove Almkvist; Anders Wall; Gunnar Antoni; Agneta Nordberg Journal: Eur J Nucl Med Mol Imaging Date: 2016-03-21 Impact factor: 9.236
Authors: Minyoung Oh; Jungsu S Oh; Seung Jun Oh; Sang Ju Lee; Jee Hoon Roh; Woo Ram Kim; Ha-Eun Seo; Jae Myeong Kang; Sang Won Seo; Jae-Hong Lee; Duk L Na; Young Noh; Jae Seung Kim Journal: J Clin Neurol Date: 2022-07 Impact factor: 2.566